1. Home
  2. SRRK vs MRCY Comparison

SRRK vs MRCY Comparison

Compare SRRK & MRCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$45.04

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Logo Mercury Systems Inc

MRCY

Mercury Systems Inc

HOLD

Current Price

$77.72

Market Cap

5.1B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRRK
MRCY
Founded
2012
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
5.1B
IPO Year
2018
1997

Fundamental Metrics

Financial Performance
Metric
SRRK
MRCY
Price
$45.04
$77.72
Analyst Decision
Strong Buy
Buy
Analyst Count
11
7
Target Price
$55.40
$80.00
AVG Volume (30 Days)
1.1M
458.2K
Earning Date
03-03-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
72.69
EPS
N/A
N/A
Revenue
N/A
$912,020,000.00
Revenue This Year
N/A
$6.59
Revenue Next Year
$449.79
$9.56
P/E Ratio
N/A
N/A
Revenue Growth
N/A
9.19
52 Week Low
$22.71
$39.89
52 Week High
$49.82
$103.81

Technical Indicators

Market Signals
Indicator
SRRK
MRCY
Relative Strength Index (RSI) 52.17 38.47
Support Level $41.54 $73.21
Resistance Level $48.29 $79.27
Average True Range (ATR) 2.49 4.38
MACD -0.28 -0.94
Stochastic Oscillator 62.43 13.78

Price Performance

Historical Comparison
SRRK
MRCY

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

About MRCY Mercury Systems Inc

Mercury Systems Inc is a commercial technology company serving the aerospace and defense industry. The company envisions, creates, and delivers secure open architecture solutions powering a broad range of mission-critical applications in challenging and demanding environments. Its Mercury Processing Platform spans the full breadth of signal processing from radio frequency front end to the human-machine interface to convert meaningful data, gathered in remote and hostile environments, into critical decisions. The company manufactures components, products, modules, and subsystems and sells to defense prime contractors, the U.S. government, original equipment manufacturers, and commercial aerospace companies. Geographically, it derives maximum revenue from the United States.

Share on Social Networks: